H1N1 California

H1N1 Influenza Virus California/04/2009 Recombinant
Cat. No.
BT25348
Source
Baculovirus Insect Cells.
Synonyms
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90.0% under the conditions that would preserve its biological activity and tertiary structure.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Hemaglutinin external envelope protein, Full-Length glycosylated H1N1 California/04/2009 with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is approximately 72 kDa.

Product Specs

Introduction
H1N1 is a subtype of the Influenza A virus. This subtype is known for its ability to mutate, resulting in various strains with varying degrees of severity. Notable strains include the Spanish Flu, mild human flu strains, endemic pig strains, and strains found in birds. The Influenza A Virus has a spherical shape with a diameter of roughly 100nm. It is enveloped in a lipid bilayer derived from its host's plasma membrane. Embedded within this membrane are two key proteins: hemagglutinin ("H") with approximately 500 molecules and neuraminidase ("N") with around 100 molecules. Internally, the virus contains 3000 molecules of matrix protein, 8 RNA segments, and multiple copies of nucleoprotein associated with each RNA molecule. Additionally, it carries several molecules of RNA polymerase subunits and other proteins with less defined functions.
Description
This product consists of the recombinant hemagglutinin external envelope protein from the H1N1 California/04/2009 strain. It is a full-length, glycosylated protein with N-linked sugars, produced in insect cells using baculovirus vectors. The molecular weight of the protein is approximately 72 kDa.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The recombinant H1N1 A/California/04/2009 protein is supplied in a solution containing 10mM Sodium phosphate (pH 7.0), 150mM Sodium Chloride, and 0.005% Tween 20.
Stability
To maintain product integrity, store the Recombinant H1N1 A/California/04/2009 at a stable temperature of 4°C. Avoid freezing.
Purity
The purity of this product is greater than 90%, ensuring the preservation of its biological activity and tertiary structure.
Source
Baculovirus Insect Cells.

Product Science Overview

Introduction

The H1N1 Influenza Virus California/04/2009, often referred to as A/California/04/2009 (H1N1), is a significant strain of the influenza A virus. This strain gained global attention during the 2009 H1N1 pandemic, commonly known as the “swine flu” pandemic. The virus is a recombinant strain, meaning it resulted from the genetic reassortment of pre-existing influenza viruses.

Origin and Genetic Makeup

The H1N1 Influenza Virus California/04/2009 emerged in April 2009 as a novel virus due to genetic reassortment between two pre-existing swine strains . This highly contagious recombinant virus contains the same genomic background as North American triple reassortant (TR) viruses, except for the neuraminidase (NA) and matrix (M) segments, which were acquired from the Eurasian swine lineage .

Structure and Function

The virus’s structure includes several key proteins, with hemagglutinin (HA) and neuraminidase (NA) being the most notable. Hemagglutinin is responsible for the virus’s ability to bind to host cells and facilitate the entry of the viral genome into the target cells by causing the fusion of the host endosomal membrane with the viral membrane . Neuraminidase, on the other hand, helps release new viral particles from infected cells, aiding in the spread of the virus within the host .

Recombinant Nature

The recombinant nature of the H1N1 Influenza Virus California/04/2009 is particularly noteworthy. The virus’s hemagglutinin (HA) and neuraminidase (NA) gene segments are derived from A/California/04/2009, while the remaining influenza viral gene segments come from A/PR/8/34 . This recombination allows the virus to possess unique properties that contribute to its virulence and transmissibility.

Impact and Significance

The 2009 H1N1 pandemic had a profound impact on global public health. The virus spread rapidly across the world, leading to widespread illness and significant mortality. The pandemic highlighted the importance of surveillance, rapid response, and vaccine development in managing influenza outbreaks. The H1N1 Influenza Virus California/04/2009 continues to be a subject of study for researchers aiming to understand its behavior, develop effective treatments, and improve preventive measures.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.